[HTML][HTML] based microfluidics: Simplified fabrication and assay methods

S Nishat, AT Jafry, AW Martinez, FR Awan - Sensors and Actuators B …, 2021 - Elsevier
Paper-based microfluidics is the branch of microfluidics involving devices made out of
paper, or other porous membranes, that wick fluids by capillary action. Paper-based …

Interpreting a covid-19 test result

J Watson, PF Whiting, JE Brush - Bmj, 2020 - bmj.com
Interpreting a covid-19 test result | The BMJ Skip to main content Intended for healthcare
professionals Access provided by Google Indexer Subscribe My Account My email alerts BMA …

Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset

B Lou, TD Li, SF Zheng, YY Su, ZY Li… - European …, 2020 - Eur Respiratory Soc
Background Timely diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection is a prerequisite for treatment and prevention. The serology characteristics …

Detection of COVID-19: A review of the current literature and future perspectives

T Ji, Z Liu, GQ Wang, X Guo, C Lai, H Chen… - Biosensors and …, 2020 - Elsevier
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led
to the coronavirus disease 2019 (COVID-19) worldwide pandemic. This unprecedented …

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

E Ortiz-Prado, K Simbaña-Rivera… - … and infectious disease, 2020 - Elsevier
Coronaviruses are an extensive family of viruses that can cause disease in both animals
and humans. The current classification of coronaviruses recognizes 39 species in 27 …

Serum iga, igm, and igg responses in covid-19

H Ma, W Zeng, H He, D Zhao, D Jiang, P Zhou… - Cellular & molecular …, 2020 - nature.com
Currently, detecting SARS-CoV-2 RNAs is a standard approach for COVID-19 diagnosis.
However, there is an urgent need for reliable and rapid serological diagnostic methods to …

The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks

G Lippi, M Plebani - Clinical Chemistry and Laboratory Medicine …, 2020 - degruyter.com
Coronavirus disease 2019, abbreviated to COVID-19 and sustained by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is the latest biological hazard to assume …

Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication

Y Chen, D Yang, B Cheng, J Chen, A Peng… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE Diabetes is one of the most distinct comorbidities of COVID-19. Here, we
describe the clinical characteristics of and outcomes in patients with diabetes in whom …

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19

K Li, B Huang, M Wu, A Zhong, L Li, Y Cai… - Nature …, 2020 - nature.com
Deciphering the dynamic changes in antibodies against SARS-CoV-2 is essential for
understanding the immune response in COVID-19 patients. Here we analyze the laboratory …

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

AL Garcia-Basteiro, G Moncunill, M Tortajada… - Nature …, 2020 - nature.com
Health care workers (HCW) are a high-risk population to acquire SARS-CoV-2 infection from
patients or other fellow HCW. This study aims at estimating the seroprevalence against …